4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) operates in the Biotechnology industry and is headquartered in Norwood, United States with about 36 employees. Its market capitalization is roughly $167 million. In the fiscal year ended 2025-12-31, CRBP reported $0M in revenue and ($78M) in net income.
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($85M) | ($49M) | ($45M) | ($35M) | — |
| Net Income | ($78M) | ($40M) | ($45M) | ($42M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($24M) | ($22M) | ($24M) | ($19M) | ($20M) | — |
| Net Income | ($23M) | ($21M) | ($23M) | ($18M) | ($17M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $168M | $156M | $28M | $66M | — |
| Total Liabilities | $21M | $14M | $35M | $33M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CRBP viewer.
About TickerBase · Data methodology & sources